MindBio Therapeutics Corp. belongs to the Health Care sector. Filings by its managers are published through SEDI. MindBio Therapeutics Corp. has had no insider filing for more than a year; the last one goes back to 22 October 2025.
Our records for MindBio Therapeutics Corp. go back to 2023, with 2 purchases and no sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEDI. Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended June 2025 · cache
8 of 8 declarations
MindBio Therapeutics Corp. is a company focused on developing psychedelic treatments for mental health disorders. It is listed on the Toronto Stock Exchange under the symbol XTSE.
Purchases our model currently ranks for the recommendations list.
All recommendations